1 1600 119 MEDIYOGA AS A PART OF A SELF-MANAGEMENT PROGRAMME AMONG PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION - A RANDOMISED STUDY. BACKGROUND: PAROXYSMAL ATRIAL FIBRILLATION IS ASSOCIATED WITH IMPAIRED HEALTH-RELATED QUALITY OF LIFE. YOGA HAS BEEN SUGGESTED TO IMPROVE HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS WITH HEART FAILURE AND HYPERTENSION. AIM: THE AIM OF THE STUDY WAS TO EVALUATE THE EFFECTS OF MEDIYOGA, IN RESPECT OF HEALTH-RELATED QUALITY OF LIFE, BLOOD PRESSURE, HEART RATE, AS WELL AS N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE, AMONG PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION, COMPARED WITH STANDARD THERAPY OR RELAXATION. METHODS: PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION, N=132, WERE STRATIFIED FOR GENDER AND RANDOMISED TO MEDIYOGA, A RELAXATION GROUP OR A CONTROL GROUP, 44 PATIENTS PER GROUP WITH A 12-WEEK FOLLOW-UP. HEALTH-RELATED QUALITY OF LIFE, BLOOD PRESSURE, HEART RATE AND N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE WERE ASSESSED. RESULTS: AFTER 12 WEEKS, THERE WERE NO DIFFERENCES IN HEALTH-RELATED QUALITY OF LIFE BETWEEN THE GROUPS. THERE WERE IMPROVEMENTS IN SHORT-FORM HEALTH SURVEY BODILY PAIN, GENERAL HEALTH, SOCIAL FUNCTION, MENTAL HEALTH AND MENTAL COMPONENT SUMMARY SCORES WITHIN THE MEDIYOGA GROUP (P=0.014, P=0.037, P=0.029, P=0.030, P=0.019, RESPECTIVELY). NO CHANGE WAS SEEN IN THE RELAXATION AND CONTROL GROUPS. SYSTOLIC BLOOD PRESSURE DECREASED IN THE MEDIYOGA GROUP (134+/-18 TO 127+/-13) COMPARED WITH THE CONTROL GROUP (126+/-17 TO 127+/-15, P=0.041); NO DIFFERENCE COMPARED WITH THE RELAXATION GROUP (131+/-17 TO 125+/-12). DIASTOLIC BLOOD PRESSURE DECREASED IN THE MEDIYOGA GROUP (79+/-9 TO 74 +/-9) COMPARED WITH THE CONTROL GROUP (76+/-9 TO 79+/-8, P=0.005); NO DIFFERENCE COMPARED WITH THE RELAXATION GROUP (76+/-9 TO 77+/-8). THERE WERE NO DIFFERENCES IN HEART RATE AND N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE BETWEEN THE GROUPS AFTER 12 WEEKS. CONCLUSIONS: MEDIYOGA IMPROVES HEALTH-RELATED QUALITY OF LIFE AND DECREASES BLOOD PRESSURE IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION. MEDIYOGA MAY BE USED AS A PART OF A SELF-MANAGEMENT PROGRAMME AMONG PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION. 2020 2 185 39 A RANDOMIZED CONTROLLED TRIAL TO STUDY THE EFFECT OF YOGA THERAPY ON CARDIAC FUNCTION AND N TERMINAL PRO BNP IN HEART FAILURE. AIMS: THE PURPOSE OF THIS STUDY WAS TO EVALUATE WHETHER YOGA TRAINING IN ADDITION TO STANDARD MEDICAL THERAPY CAN IMPROVE CARDIAC FUNCTION AND REDUCE N TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE (NT PRO BNP) IN HEART FAILURE (HF). METHODS: 130 PATIENTS WERE RECRUITED AND RANDOMIZED INTO TWO GROUPS: CONTROL GROUP (CG) (N = 65), YOGA GROUP (YG). IN YG, 44 PATIENTS AND IN CG, 48 PATIENTS COMPLETED THE STUDY. CARDIAC FUNCTION USING LEFT VENTRICULAR EJECTION FRACTION (LVEF), MYOCARDIAL PERFORMANCE INDEX (TEI INDEX), AND NT PRO BNP, A BIOMARKER OF HF, WAS ASSESSED AT BASELINE AND AFTER 12 WEEKS. RESULT: IMPROVEMENT IN LVEF, TEI INDEX, AND NT PRO BNP WERE STATISTICALLY SIGNIFICANT IN BOTH THE GROUPS. FURTHERMORE, WHEN THE CHANGES IN BEFORE AND AFTER 12 WEEKS WERE IN PERCENTAGE, LVEF INCREASED 36.88% IN THE YG AND 16.9% IN THE CG, TEI INDEX WAS REDUCED 27.87% IN THE YG AND 2.79% IN THE CG, NT PRO BNP WAS REDUCED 63.75% IN THE YG AND 10.77% IN THE CG. THE BETWEEN GROUP COMPARISONS FROM PRE TO POST 12 WEEKS WERE SIGNIFICANT FOR YG IMPROVEMENTS (LVEF, P < 0.01, TEI INDEX, P < 0.01, NT PRO BNP, P < 0.01). CONCLUSION: THESE RESULTS INDICATE THAT THE ADDITION OF YOGA THERAPY TO STANDARD MEDICAL THERAPY FOR HF PATIENTS HAS A MARKEDLY BETTER EFFECT ON CARDIAC FUNCTION AND REDUCED MYOCARDIAL STRESS MEASURED USING NT PRO BNP IN PATIENTS WITH STABLE HF. 2014 3 412 33 BLOOD PRESSURE EFFECTS OF YOGA, ALONE OR IN COMBINATION WITH LIFESTYLE MEASURES: RESULTS OF THE LIFESTYLE MODIFICATION AND BLOOD PRESSURE STUDY (LIMBS). THE AUTHORS CONDUCTED A STUDY TO ASSESS THE EFFECTS OF YOGA ON BLOOD PRESSURE (BP). PATIENTS WERE RANDOMIZED TO YOGA (BLOOD PRESSURE EDUCATION PROGRAM [BPEP]), OR A COMBINED PROGRAM (COMBO). AMBULATORY BP WAS MEASURED AT BASELINE AND AT 12 AND 24 WEEKS. DATA ARE PRESENTED FOR ALL ENROLLED PATIENTS (N=137) AND FOR COMPLETERS ONLY (N=90). SYSTOLIC BP (SBP) AND DIASTOLIC BP (DBP) WERE SIGNIFICANTLY DECREASED WITHIN ALL GROUPS AT 12 AND 24 WEEKS (P<.001) FOR ENROLLED PATIENTS AND COMPLETERS. SBP WAS SIGNIFICANTLY REDUCED IN THE YOGA AND COMBO GROUPS AS COMPARED WITH THE BPEP GROUP AT 12 WEEKS IN ALL ENROLLED AND COMPLETERS. SBP DIFFERENCES WERE NO LONGER SIGNIFICANT AT 24 WEEKS BETWEEN GROUPS IN ALL ENROLLED PATIENTS; HOWEVER, THERE WAS A GREATER REDUCTION IN SBP AT 24 WEEKS IN COMPLETERS FAVORING BPEP OVER YOGA. NO DIFFERENCES IN DBP BETWEEN GROUPS OR IN BP BETWEEN THE YOGA AND COMBO GROUPS WERE PRESENT. THE AUTHORS DID NOT OBSERVE AN ADDITIVE BENEFIT FROM COMBINING YOGA WITH BPEP MEASURES. REASONS FOR THIS ARE UNCLEAR AT THIS TIME. BP LOWERING WITH YOGA, HOWEVER, WAS SIMILAR TO THAT ACHIEVED WITH LIFESTYLE MEASURES. 2016 4 822 35 EFFECT OF YOGA ON FEV1, 6-MINUTE WALK DISTANCE (6-MWD) AND QUALITY OF LIFE IN PATIENTS WITH COPD GROUP B. INTRODUCTION: YOGA IS USED IN THE TREATMENT OF VARIOUS DISEASES, INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE. HOWEVER, NO STUDIES HAVE ASSESSED THE EFFECT OF YOGA ON COPD PATIENTS IN INDONESIA. THE DIFFERENCE BETWEEN THIS STUDY AND SIMILAR STUDIES COMPLETED IN OTHER COUNTRIES LIES IN THE TYPE OF YOGA EXERCISES COMPLETED, THE METHOD IN WHICH THEY WERE COMPLETED, AND IN CERTAIN, UNIQUE DEMOGRAPHIC CHARACTERISTICS. THIS STUDY AIMS TO ANALYZE THE EFFECT OF YOGA ON FEV1, 6-MINUTE WALK DISTANCE, AND QUALITY OF LIFE IN PATIENTS WITH COPD GROUP B IN INDONESIA. MATERIAL AND METHODS: THIS ARTICLE REFLECTS RESEARCH DONE IN THE FORM OF AN EXPERIMENTAL STUDY USING ARANDOMIZED CONTROLLED TRIAL WITH PRE AND POST-TEST CONTROL GROUP DESIGN. THE SAMPLES WERE DIVIDED INTO 2 GROUPS: THE TREATMENT GROUP (YOGA PRACTICE FOR 1 HOUR, 2 TIMES AWEEK FOR 12 WEEKS) AND THE CONTROL GROUP (UNTREATED WITH YOGA, GIVEN LUNG REHABILITATION BROCHURE). ASSESSMENT OF THE EFFECT OF YOGA EXERCISES ON LUNG FUNCTION PARAMETERS (FEV1), 6-MINUTE WALK DISTANCE AND QUALITY OF LIFE WERE USED USING SGRQ QUESTIONNAIRES IN COPD GROUP B. RESULTS: 33 COPD PATIENTS FULFILLED THE INCLUSION CRITERIA. 30 PATIENTS COMPLETED THE STUDY. PRE AND POST YOGA RESULTS WERE EVALU-ATED IN THE TREATMENT GROUP VERSUS THE CONTROL GROUP AND THEN FURTHER ASSESSED USING STATISTICAL TESTS. THERE WAS ASIGNIFICANT IN-CREASE IN FEV1, 6-MWD AND QUALITY OF LIFE USING ASGRQ QUESTIONNAIRE AFTER 12 WEEKS OF YOGA (P < 0.05) AS WELL AS AASIGNIFICANT CHANGE IN FEV1, 6-MWD AND QUALITY OF LIFE IN THE TREATMENT GROUP (P < 0.05) WHEN COMPARED WITH THE CONTROL GROUP (P > 0.05). CONCLUSIONS: YOGA AFFECTS FEV1, 6-MWD, AND QUALITY OF LIFE IN PATIENTS WITH GROUP B COPD. 2019 5 2789 40 YOGA THERAPY FOR ABDOMINAL PAIN-RELATED FUNCTIONAL GASTROINTESTINAL DISORDERS IN CHILDREN: A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: THE AIM OF THE PRESENT STUDY WAS TO COMPARE EFFECTS OF 10 WEEKS OF YOGA THERAPY (YT) AND STANDARD MEDICAL CARE (SMC) ON ABDOMINAL PAIN AND QUALITY OF LIFE (QOL) IN CHILDREN WITH ABDOMINAL PAIN-RELATED FUNCTIONAL GASTROINTESTINAL DISORDERS (AP-FGIDS). METHODS: SIXTY-NINE PATIENTS, AGES 8 TO 18 YEARS, WITH AP-FGIDS, WERE RANDOMIZED TO SMC COMPLEMENTED WITH YT OR SMC ALONE. YT IS A MIXTURE OF YOGA POSES, MEDITATION, AND RELAXATION EXERCISES AND WAS GIVEN ONCE A WEEK IN GROUP SESSIONS. SMC CONSISTED OF EDUCATION, REASSURANCE, DIETARY ADVICE, AND FIBERS/MEBEVERINE, IF NECESSARY. PAIN INTENSITY (PAIN INTENSITY SCORE [PIS] 0-5) AND FREQUENCY (PAIN FREQUENCY SCORE [PFS] 0-4) WERE SCORED IN A PAIN DIARY, AND QOL WAS MEASURED WITH KIDSCREEN-27. FOLLOW-UP WAS 12 MONTHS. TREATMENT RESPONSE WAS DEFINED AS >/=50% REDUCTION OF WEEKLY PAIN SCORES. RESULTS: AT 1-YEAR FOLLOW-UP, TREATMENT RESPONSE WAS ACCOMPLISHED IN 58% OF THE YT GROUP AND IN 29% OF THE CONTROL GROUP (P = 0.01); NO SIGNIFICANT DIFFERENCES FOR OTHER TIME POINTS WERE FOUND. YT, AND NOT SMC, RESULTED IN A SIGNIFICANT REDUCTION OF PIS (P < 0.01) AND PFS (P < 0.01) AFTER 12 MONTHS. DURING THE STUDY, HOWEVER, YT WAS NOT SIGNIFICANTLY SUPERIOR COMPARED WITH SMC. SUBANALYSES FOR TIME POINTS DEMONSTRATED A SIGNIFICANT GREATER REDUCTION OF PIS AT 12 MONTHS IN FAVOR OF YT. NO DIFFERENCES WERE FOUND FOR QOL. YT WAS MORE EFFECTIVE IN THE REDUCTION OF REPORTED MONTHLY SCHOOL ABSENCE (P = 0.03). CONCLUSION: AT 1-YEAR FOLLOW-UP, YT IN ADDITION TO STANDARD CARE WAS SUPERIOR COMPARED WITH SMC ACCORDING TO TREATMENT SUCCESS, PIS, AND REDUCTION OF SCHOOL ABSENCE. YT, HOWEVER, WAS NOT SIGNIFICANTLY MORE EFFECTIVE IN IMPROVING PFS OR QOL, COMPARED WITH SMC. 2016 6 2833 31 YOGA'S EFFECT ON FALLS IN RURAL, OLDER ADULTS. BACKGROUND: UNINTENTIONAL FALLS AFFECT 30% OF PEOPLE OVER AGE 65 YEARS. YOGA HAS BEEN SHOWN TO IMPROVE BALANCE. WE DESIGNED THIS STUDY TO EXAMINE IF YOGA REDUCES FALLS. METHODS: WE CONDUCTED 16 SESSIONS OF HATHA YOGA OVER 8 WEEKS. PARTICIPANTS WERE RANDOMLY ASSIGNED TO PRACTICE 10MIN OF YOGA DAILY AT HOME IN ADDITION TO 5-MIN RELAXATION EXERCISES OR RELAXATION EXERCISES ONLY (CONTROL GROUP). RESULTS: OF THE 38 PARTICIPANTS COMPLETING THE INTERVENTION, 15 PARTICIPANTS REPORTED A TOTAL OF 27 FALLS IN THE 6-MONTHS BEFORE THE STUDY, COMPARED TO 13 PARTICIPANTS SUSTAINING 14 FALLS IN THE 6 MONTHS FROM THE START OF THE STUDY (P<0.047), WITHOUT DIFFERENCE BETWEEN YOGA HOME-EXERCISE AND HOME RELAXATION-ONLY GROUPS. COMPARED TO BASELINE SCORES, ALL PARTICIPANTS IMPROVED ON THE BERG BALANCE SCALE (53-54 OUT OF 56, P=0.002), THE FUNCTIONAL GAIT ASSESSMENT (22.9-25.8 OUT OF 30 POINTS, P<0.001), AND THE DYNAMIC GAIT INDEX (20.6-22.4 OUT OF 24 POINTS, P<0.001). RIGHT LEG STAND TIME IMPROVED FROM A MEAN OF 13.3S TO 17.1S (P=0.020) AND STANDING FORWARD REACH DISTANCE FROM 26.0CM TO 29.6CM (P<0.001). WITHOUT DIFFERENCE BETWEEN GROUPS. CONFIDENCE, WITH THE ACTIVITIES-SPECIFIC BALANCE CONFIDENCE SCALE, INCREASED IN THE YOGA HOME-EXERCISE GROUP (88%-93%, P=0.037) COMPARED TO 90% UNCHANGED FROM PRE-INTERVENTION IN THE HOME RELAXATION-ONLY GROUP. CONCLUSION: YOGA CLASSES REDUCE SELF-REPORTED FALLS AND IMPROVE BALANCE MEASURES. THE ADDITION OF HOME YOGA EXERCISES DID NOT ENHANCE BENEFIT OVER RELAXATION EXERCISE ONLY. 2017 7 712 30 EFFECT OF INTEGRATED YOGA ON ANTI-PSYCHOTIC INDUCED SIDE EFFECTS AND COGNITIVE FUNCTIONS IN PATIENTS SUFFERING FROM SCHIZOPHRENIA. BACKGROUND TWENTY ONE (12 FEMALES) SUBJECTS, DIAGNOSED WITH SCHIZOPHRENIA BY A PSYCHIATRIST USING ICD-10, IN THE AGES 52.87 + 9.5YEARS AND SUFFERING SINCE 24.0 +/- 3.05YEARS WERE RECRUITED INTO THE STUDY FROM A SCHIZOPHRENIA REHABILITATION CENTER IN BENGALURU. METHODS ALL SUBJECTS WERE TAKING ANTI-PSYCHOTIC MEDICATIONS AND WERE IN STABLE STATE FOR MORE THAN A MONTH. PSYCHIATRIC MEDICATIONS WERE KEPT CONSTANT DURING THE STUDY PERIOD. ASSESSMENTS WERE DONE AT THREE POINTS OF TIME: (1) BASELINE, (2) AFTER ONE MONTH OF USUAL ROUTINE (PRE) AND (3) AFTER FIVE MONTHS OF VALIDATED INTEGRATED YOGA (IY) INTERVENTION (POST). VALIDATED 1H YOGA MODULE (CONSISTING OF ASANAS, PRANAYAMA, RELAXATION TECHNIQUES AND CHANTINGS) WAS PRACTICED FOR 5MONTHS, FIVE SESSIONS PER WEEK. ANTIPSYCHOTIC-INDUCED SIDE EFFECTS WERE ASSESSED USING SIMPSON ANGUS SCALE (SAS) AND UDVALG FOR KLINISKE UNDERSOGELSER (UKU) SIDE EFFECT RATING SCALE. COGNITIVE FUNCTIONS (USING TRAIL MAKING TEST A AND B), CLINICAL SYMPTOMS AND ANTHROPOMETRY WERE ASSESSED AS SECONDARY VARIABLES. COMPARISONS BETWEEN "PRE" AND "POST" DATA WAS DONE USING PAIRED SAMPLES T-TESTS AFTER SUBTRACTING BASELINE SCORES FROM THEM RESPECTIVELY. RESULTS AT THE END OF FIVE MONTHS, SIGNIFICANT REDUCTION IN DRUG-INDUCED PARKINSONIAN SYMPTOMS (SAS SCORE; P=0.001) AND 38 ITEMS OF UKU SCALE WAS OBSERVED ALONG WITH SIGNIFICANT IMPROVEMENT IN PROCESSING SPEED, EXECUTIVE FUNCTIONS AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA PATIENTS. NO SIDE EFFECTS OF YOGA WERE REPORTED. CONCLUSIONS THE PRESENT STUDY PROVIDES PRELIMINARY EVIDENCE FOR USEFULNESS OF INTEGRATED YOGA INTERVENTION IN MANAGING ANTI-PSYCHOTIC-INDUCED SIDE EFFECTS. 2018 8 2173 31 THE EFFECTS OF YOGA ON DYSPNEA, SLEEP AND FATIGUE IN CHRONIC RESPIRATORY DISEASES. PURPOSE: THIS STUDY WAS CARRIED OUT TO FIND OUT THE EFFECTS OF YOGA APPLIED TO CHRONIC RESPIRATORY DISEASE PATIENTS ON DYSPNEA, SLEEP QUALITY AND FATIGUE. MATERIAL AND METHOD: THE STUDY WAS CONDUCTED BETWEEN MAY AND AUGUST 2020 AS A RANDOMIZED CONTROLLED STUDY. 'PERSONAL INFORMATION FORM', 'RESPIRATORY FUNCTIONS MONITORING FORM', 'COPD AND ASTHMA FATIGUE SCALE (CAFS), "ASTHMA AND COPD SLEEP IMPACT SCALE (CASIS)" AND MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE (MMRC) WERE USED IN DATA COLLECTION. RESULTS: WHEN THE POST-TEST MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP WERE COMPARED, IT WAS FOUND THAT CAFS, CASIS AND MMRC MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL GROUP DECREASED POSITIVELY COMPARED TO THE PATIENTS IN THE CONTROL GROUP AND THE DIFFERENCE BETWEEN WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.05). CONCLUSION: YOGA HAS BEEN FOUND TO REDUCE THE SEVERITY OF DYSPNEA AND FATIGUE AND IMPROVE SLEEP QUALITY IN CHRONIC RESPIRATORY DISEASES. 2021 9 2905 29 [LONG-TERM EFFECTS OF BREATHING EXERCISES AND YOGA IN PATIENTS WITH BRONCHIAL ASTHMA]. TO COMPARE THE EFFECTS OF BREATHING EXERCISES (BE) OR YOGA (Y) ON THE COURSE OF BRONCHIAL ASTHMA WE STUDIED 36 SUBJECTS WITH A MILD DISEASE. THE PATIENTS WERE RANDOMLY DIVIDED INTO 3 GROUPS. 2 OF THEM PARTICIPATED IN A 3 WEEKS TRAINING PROGRAM OF BE OR Y WHILE THE THIRD GROUP RESTED WITHOUT ANY ADDITIONAL TREATMENT (CONTROL GROUP, C). AT THE END OF THE TRAINING PERIOD THE PATIENTS WERE ASKED TO PRACTISE BE OR Y ON THEIR OWN. DRUG THERAPY AND LUNG FUNCTION PARAMETERS BEFORE AND AFTER A BETA 2-AGONIST METERED DOSE INHALER (ALBUTEROL, ALB) WERE RECORDED PRIOR TO THE TRAINING PROGRAM AND IN 4 WEEKS INTERVALS FOR 4 MONTHS THEREAFTER. THE RESPONSE TO THE BETA 2-AGONIST WAS DOCUMENTED CONTINUOUSLY IN 28 PATIENTS. THE MENTAL STATE OF THE PATIENTS WAS ELUCIDATED BY QUESTIONNAIRES.--PRIOR TO THE STUDY A SIGNIFICANT EFFECT OF INHALED ALB ON THE FEV1 WAS SHOWN WITHOUT ANY SIGNIFICANT BETWEEN GROUP DIFFERENCES. BOTH, BE AND Y, CAUSED A SIGNIFICANT AMELIORATION OF THE MENTAL STATE BUT ONLY THE BE INDUCED A SIGNIFICANT IMPROVEMENT OF LUNG FUNCTION PARAMETERS COMPARED TO THE INDIVIDUAL BASELINE VALUES. THE FEV1 INCREASED SIGNIFICANTLY BY 356.3 +/- 146.2 ML (P < 0.05) AND THE VC BY 225.0 +/- 65.5 ML (P < 0.01). THESE LONG-TERM CHANGES WERE NOT SIGNIFICANTLY DIFFERENT FROM THE ACTUAL RESPONSE TO ALB. BE DECREASED THE RV SIGNIFICANTLY BY 306.3 +/- 111.6 ML (P < 0.05), AN EFFECT SIGNIFICANTLY HIGHER COMPARED TO THE BETA 2-AGONIST (P < 0.01). BE IN COMBINATION WITH ALB CAUSED AN ADDITIVE EFFECT.(ABSTRACT TRUNCATED AT 250 WORDS) 1994 10 2115 25 THE EFFECT OF YOGA ON THE QUALITY OF LIFE IN THE CHILDREN AND ADOLESCENTS WITH HAEMOPHILIA. THE PROBLEMS CAUSED BY HAEMOPHILIA LEAD TO IMPAIRMENTS OF THE QUALITY OF LIFE IN PATIENTS WITH HAEMOPHILIA. THIS STUDY AIMED TO INVESTIGATE THE EFFECTS OF YOGA ON QUALITY OF LIFE IN THE CHILDREN AND ADOLESCENTS WITH HAEMOPHILIA IN SHIRAZ, IRAN. THIS SEMI-EXPERIMENTAL STUDY WITH PRE- AND POST-TEST DESIGN WAS PERFORMED ON 27 BOYS BETWEEN 8 AND 16 YEARS OLD WHO SUFFERED FROM HAEMOPHILIA. THE PATIENTS WERE DIVIDED INTO TWO GROUPS. THE NUMBER OF BLEEDINGS, ABSENCES FROM SCHOOL, AND REFERRALS TO THE CLINIC WAS EVALUATED. THE DEMOGRAPHIC DATA WERE COLLECTED THROUGH INTERVIEWS AND USING THE PATIENTS' RECORDS IN THE HAEMOPHILIA CENTER. BESIDES, THE QUALITY OF LIFE WAS ASSESSED THROUGH THE HAEMO-QOL QUESTIONNAIRE. THEN, THE YOGA INTERVENTION WAS PERFORMED FOR 14 WEEKS AND THE DATA WERE COLLECTED IN THREE STAGES. THE COLLECTED DATA WERE ENTERED INTO THE SPSS STATISTICAL SOFTWARE, VERSION 18 AND WERE ANALYZED USING NON-PARAMETRIC FRIEDMAN TEST. AFTER THE INTERVENTION, SIGNIFICANT DIFFERENCES WERE OBSERVED IN THE MEAN SCORES OF QUALITY OF LIFE DIMENSIONS AND THE NUMBER OF BLEEDINGS, SCHOOL ABSENCES, AND REFERRALS TO THE HAEMOPHILIA CLINIC (P<0.001). THUS, YOGA MAY IMPROVE THE HAEMOPHILIA CHILDREN'S AND ADOLESCENTS' PERCEPTION OF QUALITY OF LIFE WITHOUT THE RISK OF INJURY. THIS INTERVENTION ALSO SEEMED TO BE EFFECTIVE IN REDUCING THE NUMBER OF BLEEDINGS, REFERRALS TO THE HAEMOPHILIA CLINIC, AND ABSENCES FROM SCHOOL. 2015 11 1852 37 RANDOMISED CLINICAL TRIAL: YOGA VS A LOW-FODMAP DIET IN PATIENTS WITH IRRITABLE BOWEL SYNDROME. BACKGROUND: IRRITABLE BOWEL SYNDROME IS THE MOST FREQUENT GASTROINTESTINAL DISORDER. IT IS ASSUMED THAT LIFESTYLE INTERVENTIONS MIGHT BE A RATIONAL TREATMENT APPROACH. AIM: TO EXAMINE THE EFFECT OF A YOGA-BASED INTERVENTION VS A LOW-FODMAP DIET ON PATIENTS WITH IRRITABLE BOWEL SYNDROME. METHODS: FIFTY-NINE PATIENTS WITH IRRITABLE BOWEL SYNDROME UNDERTOOK A SINGLE-BLIND, RANDOMISED CONTROLLED TRIAL INVOLVING YOGA OR A LOW-FODMAP DIET FOR 12 WEEKS. PATIENTS IN THE YOGA GROUP RECEIVED TWO SESSIONS WEEKLY, WHILE PATIENTS IN THE LOW-FODMAP GROUP RECEIVED A TOTAL OF THREE SESSIONS OF NUTRITIONAL COUNSELLING. THE PRIMARY OUTCOME WAS A CHANGE IN GASTROINTESTINAL SYMPTOMS (IBS-SSS). SECONDARY OUTCOMES EXPLORED CHANGES IN QUALITY OF LIFE (IBS-QOL), HEALTH (SF-36), PERCEIVED STRESS (CPSS, PSQ), BODY AWARENESS (BAQ), BODY RESPONSIVENESS (BRS) AND SAFETY OF THE INTERVENTIONS. OUTCOMES WERE EXAMINED IN WEEKS 12 AND 24 BY ASSESSORS "BLINDED" TO PATIENTS' GROUP ALLOCATION. RESULTS: NO STATISTICALLY SIGNIFICANT DIFFERENCE WAS FOUND BETWEEN THE INTERVENTION GROUPS, WITH REGARD TO IBS-SSS SCORE, AT EITHER 12 (DELTA = 31.80; 95%CI = -11.90, 75.50; P = .151) OR 24 WEEKS (DELTA = 33.41; 95%CI = -4.21, 71.04; P = .081). WITHIN-GROUP COMPARISONS SHOWED STATISTICALLY SIGNIFICANT EFFECTS FOR YOGA AND LOW-FODMAP DIET AT BOTH 12 AND 24 WEEKS (ALL P < .001). COMPARABLE WITHIN-GROUP EFFECTS OCCURRED FOR THE OTHER OUTCOMES. ONE PATIENT IN EACH INTERVENTION GROUP EXPERIENCED SERIOUS ADVERSE EVENTS (P = 1.00) AND ANOTHER, ALSO IN EACH GROUP, EXPERIENCED NONSERIOUS ADVERSE EVENTS (P = 1.00). CONCLUSIONS: PATIENTS WITH IRRITABLE BOWEL SYNDROME MIGHT BENEFIT FROM YOGA AND A LOW-FODMAP DIET, AS BOTH GROUPS SHOWED A REDUCTION IN GASTROINTESTINAL SYMPTOMS. MORE RESEARCH ON THE UNDERLYING MECHANISMS OF BOTH INTERVENTIONS IS WARRANTED, AS WELL AS EXPLORATION OF POTENTIAL BENEFITS FROM THEIR COMBINED USE. 2018 12 1969 37 SHORT TERM EFFECT OF YOGA ASANA - AN ADJUNCT THERAPY TO CONVENTIONAL TREATMENT IN FROZEN SHOULDER. BACKGROUND: THE AVAILABLE TREATMENTS FOR FROZEN SHOULDER YIELD VARIABLE RESULTS. PHYSICAL THERAPY AND ANALGESICS ARE CONSIDERED AS THE FIRST-LINE TREATMENT FOR THIS DISORDER, BUT THE EFFECTS ARE NOT UNIFORM. THERE IS SOME EVIDENCE TO SUPPORT THAT ALTERNATIVE MEDICINE MAY HAVE A ROLE IN ITS MANAGEMENT. OBJECTIVE(S): THIS STUDY WAS DESIGNED TO EXAMINE THE SHORT-TERM EFFECTS OF YOGA THERAPY IN PATIENTS WITH FROZEN SHOULDER OF MILD TO MODERATE SEVERITY. MATERIALS AND METHODS: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL WAS CONDUCTED ON PATIENTS WITH FROZEN SHOULDER BETWEEN 30 AND 60 YEARS OF AGE. THEY WERE DIVIDED INTO TWO GROUPS: YOGA (Y) AND CONTROL (NY). A SET OF ASANA EXERCISES CALLED "STANDING GROUP OF ASANA" WAS PRACTICED BY THE YOGA GROUP IN ADDITION TO THE CONVENTIONAL THERAPY AS RECEIVED BY THE CONTROL GROUP. THE PATIENTS WERE REVIEWED AT 1, 2 AND 4 WEEKS. THE PAIN AND FUNCTIONAL ASSESSMENT WERE DONE AT BASELINE AND AT EACH REVIEW USING THE SHOULDER PAIN AND DISABILITY INDEX (SPADI). RESULTS: THERE WERE 16 MALE AND 20 FEMALE PARTICIPANTS IN THE Y GROUP, AND 15 MALES AND 21 FEMALES IN THE NY GROUP. THERE WAS NO STATISTICALLY SIGNIFICANT DIFFERENCE IN AGE, SEX, AND PRE-TREATMENT SPADI SCORE BETWEEN THE GROUPS. AT THE END OF THE FOUR WEEKS, THE SPADI PAIN SCORES IN THE Y AND NY GROUP WERE 20.47 AND 20.14, RESPECTIVELY (P = 0.666). THE SPADI DISABILITY SCORES IN THE Y AND NY GROUP WERE 20.4 AND 19.7, RESPECTIVELY (P = 0.599). OVERALL SPADI SCORES WERE 40.67 AND 40.03 IN THE Y AND NY GROUP, RESPECTIVELY (P = 0.736). BOTH GROUPS HAD A SIGNIFICANT REDUCTION IN SPADI PAIN AND DISABILITY SCORES. HOWEVER, THERE WAS NO SIGNIFICANT DIFFERENCE BETWEEN THE GROUPS IN TERMS OF SPADI SCORES. CONCLUSION: THE EFFECT OF THE STANDING GROUP OF ASANA HAS NO ADDED ADVANTAGE RELATIVE TO STANDARD FROZEN SHOULDER TREATMENT WHEN PRACTICED FOR ONE MONTH. 2020 13 1809 39 PREVENTIVE EFFECTS OF A THREE-MONTH YOGA INTERVENTION ON ENDOTHELIAL FUNCTION IN PATIENTS WITH MIGRAINE. BACKGROUND: MIGRAINE IS A NEUROVASCULAR DISORDER AND ANY INTERVENTIONS IMPROVING ENDOTHELIAL FUNCTION MAY CONTRIBUTE TO ITS TREATMENT AND PREVENTION OF VASCULAR COMPLICATIONS LIKE ISCHEMIC STROKE. YOGA HAS BEEN SHOWN TO HAVE SEVERAL BENEFICIAL EFFECTS ON CARDIOVASCULAR SYSTEMS. HOWEVER, NO RANDOMIZED CONTROLLED STUDIES TO DATE HAVE INVESTIGATED ITS EFFECTS ON ENDOTHELIAL FUNCTION OF MIGRAINEURS. METHODS: A TOTAL OF 42 WOMEN PATIENTS WITH MIGRAINE WERE ENROLLED AND RANDOMIZED INTO EITHER A YOGA EXERCISE GROUP OR A CONTROL GROUP. THE CONTROL GROUP RECEIVED ONLY MEDICATION FOR 12 WEEKS AND THE YOGA GROUP WAS PLACED IN YOGA TRAINING PROGRAM IN ADDITION TO THE SAME MEDICAL TREATMENT. BLOOD TEST WAS GIVEN FROM ALL PATIENTS IN ORDER TO MEASURE PLASMA LEVELS INTERCELLULAR ADHESION MOLECULE (ICAM) AND VASCULAR CELL ADHESION MOLECULE (VCAM) AFTER YOGA TRAINING PROGRAM. RESULTS: TOTALLY 32 PATIENTS WERE PARTICIPATED IN THE FINAL ANALYSES (YOGA: N = 18, CONTROL: N = 14). BY ANALYZING DATA BETWEEN YOGA AND CONTROL GROUPS AFTER THE TREATMENT PERIOD, THERE WAS A SIGNIFICANT DECREASED IN PLASMA LEVEL OF VCAM IN YOGA GROUP COMPARE WITH THE CONTROL GROUP (15.29 +/- 2.1 NG/ML VS. 21.70 +/- 3.0 NG/ML, P < 0.05), WHEREAS THERE WAS NO SIGNIFICANT DIFFERENCE IN ICAM LEVEL BETWEEN GROUPS (19.1 +/- 1.8 NG/ML VS. 20.97 +/- 1.9 NG/ML P > 0.05). CONCLUSIONS: IT SEEMS THAT YOGA EXERCISES, AS A COMPLEMENTARY TREATMENT BESIDE PHARMACOLOGICAL TREATMENTS, CAN BE POTENTIALLY AN EFFECTIVE WAY OF IMPROVING VASCULAR FUNCTIONS IN MIGRAINEURS. 2014 14 1571 29 MANAGEMENT OF MYOFASCIAL PAIN DYSFUNCTION SYNDROME WITH MEDITATION AND YOGA: HEALING THROUGH NATURAL THERAPY. AIMS AND OBJECTIVES: AIMS AND OBJECTIVES OF THE STUDY WERE TO STUDY THE EFFECTIVENESS OF RAJ-YOGA MEDITATION AND PRANAYAMA IN PATIENTS WITH MYOFASCIAL PAIN DYSFUNCTION SYNDROME (MPDS) AND COMPARED THE EFFECTS WITH ONGOING CONVENTIONAL NONINVASIVE TREATMENT MODALITIES. MATERIALS AND METHODS: THE STUDY COMPRISED 30 PATIENTS DIVIDED EQUALLY (10 EACH) INTO 3 GROUP, I.E., CONTROL GROUP (CONVENTIONAL, NONINVASIVE TREATMENT), EXPERIMENTAL A GROUP (CONVENTIONAL, NONINVASIVE TREATMENT WITH RAJ-YOGA MEDITATION THERAPY AND PRANAYAMA), AND EXPERIMENTAL B GROUP (RAJ-YOGA MEDITATION THERAPY AND PRANAYAMA ONLY). PARAMETERS SUCH AS PAIN, MOUTH OPENING, MANDIBULAR DEVIATION, INFLAMMATION, SWELLING, CLICKING, OCCLUSION, AND PSYCHOLOGIC EVALUATION SUCH AS ANXIETY, STRESS, AND DEPRESSION WERE ASSESSED BEFORE THE START OF THE STUDY AND AT WEEKLY INTERVALS FOR 3 MONTHS. RESULTS: POSTTREATMENT PAIN AND INFLAMMATION IMPROVED BOTH IN THE CONTROL GROUP AND EXPERIMENTAL A GROUP, BUT STATISTICALLY IT IS HIGHLY SIGNIFICANT IN THE EXPERIMENTAL A GROUP. FURTHERMORE, IT IS EFFECTIVE IMMEDIATELY AS WELL AS FOR A LONG PERIOD IN EXPERIMENTAL A GROUP. IMPROVEMENT IN MOUTH OPENING WAS STATISTICALLY HIGHLY SIGNIFICANT IN CONTROL GROUP BUT NOT IN THE EXPERIMENTAL GROUPS. POSTTREATMENT ANXIETY AND STRESS STATUS WAS IMPROVED WITH STATISTICALLY HIGHLY SIGNIFICANT RESULT IN THE EXPERIMENTAL A AND B. THE POSTTREATMENT DEPRESSION STATUS ALONG WITH MANDIBULAR DEVIATION, SWELLING, CLICKING, AND OCCLUSION HAS NOT IMPROVED SIGNIFICANTLY IN ANY OF THE GROUPS. INTERPRETATION AND CONCLUSION: RAJ-YOGA MEDITATION AND PRANAYAMA IN COMBINATION WITH CONVENTIONAL, NONINVASIVE, TREATMENT MODALITIES SHOWED PROMISING RESULTS IN MPDS PATIENTS AS COMPARED TO EITHER MODALITIES ALONE. 2018 15 789 34 EFFECT OF YOGA EXERCISE ON PREMENSTRUAL SYMPTOMS AMONG FEMALE EMPLOYEES IN TAIWAN. YOGA CLASSES DESIGNED FOR WOMEN WITH PREMENSTRUAL SYNDROME ARE AVAILABLE, BUT THEIR EFFICACY IS UNCLEAR. WE INVESTIGATED THE EFFECTS OF 12 WEEKS' YOGA EXERCISE (YOGA INTERVENTION) ON PREMENSTRUAL SYMPTOMS IN MENSTRUATING FEMALES IN TAIWAN. SIXTY-FOUR SUBJECTS COMPLETED THE YOGA INTERVENTION, AND BEFORE AND AFTER THE INTERVENTION FILLED OUT A STRUCTURED SELF-REPORT QUESTIONNAIRE ABOUT THEIR DEMOGRAPHICS, PERSONAL LIFESTYLE, MENSTRUAL STATUS, BASELINE MENSTRUAL PAIN SCORES, PREMENSTRUAL SYMPTOMS, AND HEALTH-RELATED QUALITY OF LIFE. OF 64 SUBJECTS, 90.6% REPORTED EXPERIENCING MENSTRUAL PAIN DURING MENSTRUATION. AFTER THE YOGA INTERVENTION, SUBJECTS REPORTED DECREASED USE OF ANALGESICS DURING MENSTRUATION (P = 0.0290) AND DECREASED MODERATE OR SEVERE EFFECTS OF MENSTRUAL PAIN ON WORK (P = 0.0011). THE YOGA EXERCISE INTERVENTION WAS ASSOCIATED WITH THE IMPROVEMENT OF THE SCALE OF PHYSICAL FUNCTION (P = 0.0340) AND BODILY PAIN (P = 0.0087) OF THE SF-36, AND SIGNIFICANTLY DECREASED ABDOMINAL SWELLING (P = 0.0011), BREAST TENDERNESS (P = 0.0348), ABDOMINAL CRAMPS (P = 0.0016), AND COLD SWEATS (P = 0.0143). MENSTRUAL PAIN MITIGATION AFTER YOGA EXERCISE CORRELATED WITH IMPROVEMENT IN SIX SCALES OF THE SF-36 (PHYSICAL FUNCTION, BODILY PAIN, GENERAL HEALTH PERCEPTION, VITALITY/ENERGY, SOCIAL FUNCTION, MENTAL HEALTH). EMPLOYERS CAN EDUCATE FEMALE EMPLOYEES ABOUT THE BENEFITS OF REGULAR EXERCISE SUCH AS YOGA, WHICH MAY DECREASE PREMENSTRUAL DISTRESS AND IMPROVE FEMALE EMPLOYEE HEALTH. 2016 16 1081 39 EFFECTS OF YOGA ON SEXUAL FUNCTION IN WOMEN WITH METABOLIC SYNDROME: A RANDOMIZED CONTROLLED TRIAL. INTRODUCTION: FEMALE SEXUAL DYSFUNCTION IS AN IMPORTANT PUBLIC HEALTH ISSUE; IT HAS A HIGH GLOBAL PREVALENCE, BUT NO EFFECTIVE AND SAFE TREATMENT OPTIONS. THE PREVALENCE OF SEXUAL DYSFUNCTION IS HIGHER IN WOMEN WITH METABOLIC SYNDROME THAN IN THE GENERAL POPULATION. AIM: THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFICACY OF YOGA AS A TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME. METHODS: IN THIS RANDOMIZED, CONTROLLED STUDY, 41 WOMEN WITH METABOLIC SYNDROME (AGE 30-60 YEARS) WERE ASSIGNED TO A 12-WEEK YOGA EXERCISE GROUP (N=20) OR A WAIT-LISTED CONTROL GROUP (N=21). MAIN OUTCOME MEASURES: PRIMARY END POINTS WERE CHANGES IN TOTAL AND INDIVIDUAL DOMAIN SCORES ON THE FEMALE SEXUAL FUNCTION INDEX. RESULTS: THE 12-WEEK YOGA INTERVENTION RESULTED IN SIGNIFICANT IMPROVEMENT IN AROUSAL (0.74+/-1.18 VS. 0.16+/-0.82, RESPECTIVELY; P=0.042) AND LUBRICATION (0.72+/-1.12 VS. 0.06+/-0.87, RESPECTIVELY; P=0.008) COMPARED WITH THE CONTROL GROUP. SYSTOLIC BLOOD PRESSURE SHOWED SIGNIFICANTLY GREATER IMPROVEMENT IN THE YOGA GROUP THAN IN THE CONTROL GROUP AT THE 12-WEEK FOLLOW UP (-3.5+/-13.7 VS. 2.0+/-14.7, RESPECTIVELY; P=0.040). CONCLUSION: THESE FINDINGS SUGGEST THAT YOGA MAY BE AN EFFECTIVE TREATMENT FOR SEXUAL DYSFUNCTION IN WOMEN WITH METABOLIC SYNDROME AS WELL AS FOR METABOLIC RISK FACTORS. 2013 17 2653 48 YOGA IMPROVES OCCUPATIONAL PERFORMANCE, DEPRESSION, AND DAILY ACTIVITIES FOR PEOPLE WITH CHRONIC PAIN. BACKGROUND: CHRONIC PAIN IS A COMPLEX ACCUMULATION OF PHYSICAL, PSYCHOLOGICAL, AND SOCIAL CONDITIONS, THUS INTERVENTIONS THAT ADDRESS PAIN AND PROMOTE OCCUPATIONAL PERFORMANCE ARE NEEDED. A HOLISTIC INTERVENTION, WITH MIND AND BODY COMPONENTS, IS LIKELY NECESSARY TO BEST TREAT THE COMPLEXITIES OF CHRONIC PAIN. THUS, WE DEVELOPED AND TESTED A YOGA INTERVENTION FOR PEOPLE WITH CHRONIC PAIN. OBJECTIVES: IN A RANDOMIZED CONTROL TRIAL (RCT), PARTICIPANTS WITH CHRONIC PAIN WERE RANDOMIZED TO A YOGA INTERVENTION OR USUAL CARE GROUP. BETWEEN AND WITHIN GROUP DIFFERENCES FOR PRE-AND POST-OUTCOME MEASURE SCORES WERE ASSESSED FOR: OCCUPATIONAL PERFORMANCE, COMPLETION OF ACTIVITIES, AND DEPRESSION. METHODS: PILOT RCT WITH PARTICIPANT ALLOCATION TO 8 WEEKS OF YOGA OR USUAL CARE. BOTH GROUPS RECEIVED ONGOING MONTHLY SELF-MANAGEMENT PROGRAMMING. DATA WERE COLLECTED BEFORE AND AFTER THE 8-WEEK INTERVENTION. PARTICIPANTS WERE RANDOMIZED TO YOGA OR USUAL CARE AFTER BASELINE ASSESSMENTS. DEMOGRAPHICS WERE COLLECTED AND MEASURES INCLUDED: CANADIAN OCCUPATIONAL PERFORMANCE MEASURE (COPM) TO ASSESS OCCUPATIONAL PERFORMANCE; THE 15-ITEM FRENCHAY ACTIVITIES INDEX (FAI)(ACTIVITIES); AND THE 9-ITEM PATIENT HEALTH QUESTIONNAIRE (PHQ-9) FOR DEPRESSION. INDEPENDENT T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN GROUPS. PAIRED T-TESTS WERE USED TO ASSESS DIFFERENCES BETWEEN PRE- AND POST 8-WEEK INTERVENTION FOR BOTH THE YOGA AND THE USUAL CARE GROUPS. PERCENT CHANGE SCORES AND EFFECT SIZES WERE CALCULATED. RESULTS: 83 PEOPLE WERE RECRUITED FOR THE STUDY AND COMPLETED BASELINE ASSESSMENTS; 44 INDIVIDUALS WERE RANDOMIZED TO YOGA AND 39 TO THE CONTROL GROUP. THE AVERAGE AGE OF ALL PARTICIPANTS WAS 51.4+/-10.5 YEARS, 68% WERE FEMALE; AND 60% HAD AT LEAST SOME COLLEGE EDUCATION. THERE WERE NO SIGNIFICANT DIFFERENCES IN DEMOGRAPHICS OR OUTCOME MEASURES BETWEEN GROUPS AT BASELINE OR 8 WEEKS; HOWEVER, THE STUDY WAS NOT POWERED TO SEE SUCH DIFFERENCES. INDIVIDUALS RANDOMIZED TO THE CONTROL GROUP DID NOT SIGNIFICANTLY IMPROVE IN ANY OUTCOME MEASURE OVER THE 8 WEEKS. THERE WERE SIGNIFICANT IMPROVEMENTS IN COPM PERFORMANCE AND COPM SATISFACTION SCORES FOR INDIVIDUALS RANDOMIZED TO THE YOGA GROUP; BOTH SCORES SIGNIFICANTLY IMPROVED. COPM PERFORMANCE IMPROVED BY 27% WITH A MODERATE TO LARGE EFFECT SIZE (3.66+/-1.85 VS 4.66+/-1.93, P < 0.001, D = 0.76). COPM SATISFACTION SIGNIFICANTLY IMPROVED BY 78% (2.14+/-2.31 VS. 3.80+/-2.50, P < 0.001) AND HAD A LARGE EFFECTS SIZE (D = 1.02). FAI SCORES IMPROVED, INDICATING INCREASED ACTIVITY OR ENGAGEMENT IN DAILY OCCUPATION DURING THE 8-WEEK INTERVENTION. SCORES INCREASED BY 5% (38.13+/-8.48 VS. 39.90+/-8.57, P = 0.024) WITH A SMALL EFFECT SIZE (D = 0.37). DEPRESSION SIGNIFICANTLY DECREASED FROM 13.21+/-5.60 TO 11.41+/-5.82, P = 0.041, WITH A SMALL EFFECT SIZE. CONCLUSION: DATA FROM THIS PILOT RCT INDICATE YOGA MAY BE AN EFFECTIVE THERAPEUTIC INTERVENTION WITH PEOPLE IN CHRONIC PAIN TO IMPROVE OCCUPATIONAL PERFORMANCE, INCREASE ENGAGEMENT IN ACTIVITIES, AND DECREASE DEPRESSION. OCCUPATIONAL THERAPY PRACTITIONERS MAY CONSIDER ADDING YOGA AS A TREATMENT INTERVENTION TO ADDRESS THE NEEDS OF PEOPLE WITH PAIN. 2019 18 830 39 EFFECT OF YOGA ON MENTAL HEALTH: COMPARATIVE STUDY BETWEEN YOUNG AND SENIOR SUBJECTS IN JAPAN. BACKGROUND: JAPAN HAS A LARGE NUMBER OF SENIOR CITIZENS. YOGA CAN BE WISELY APPLIED IN OLD AGE CARE. THERE IS NO ANY AGE RESTRICTION TO PRACTICE YOGA. THE EFFECT MAY DIFFER BY AGE. THERE IS A NEED TO STUDY THE MECHANISM OF ACTION OF YOGA WITH RESPECT TO AGE. AIM: THIS STUDY WAS CONDUCTED IN JAPAN TO FIND THE EFFECT OF YOGA ON MENTAL HEALTH BETWEEN YOUNG AND SENIOR PEOPLE. MATERIALS AND METHODS: TWENTY-FIVE NORMAL HEALTHY VOLUNTEERS OF BOTH SEXES WERE DIVIDED INTO TWO GROUPS ACCORDING TO AGE. FIFTEEN PARTICIPANTS OF THE AGE GROUP BETWEEN 65 TO 75 YEARS AND 10 PARTICIPANTS OF THE AGE GROUP BETWEEN 20 TO 30 YEARS WERE SELECTED. THIS STUDY WAS APPROVED BY THE ETHICAL COMMITTEE OF KAWASAKI UNIVERSITY OF MEDICAL WELFARE. SELECTED INDIVIDUALS WERE SUBJECTED TO 90 MIN OF YOGA CLASSES ONCE OR TWICE A WEEK FOR A MONTH. SALIVARY AMYLASE ACTIVITY WAS ASSESSED BEFORE AND AFTER YOGA PRACTICE. STATE TRAIT ANXIETY INVENTORY (STAI) WAS GIVEN BEFORE YOGA ON THE FIRST DAY AND AFTER ONE MONTH OF PRACTICE TO ASSESS THE CHANGE IN STATE ANXIETY AND TRAIT ANXIETY. RESULTS: SENIOR GROUP - SALIVARY AMYLASE ACTIVITY DECREASED FROM 111.2+/-42.7 TO 83.48+/-39.5 KU/L [AVERAGE+/-STANDARD DEVIATION]. YOUNGER GROUP - SALIVARY AMYLASE ACTIVITY REDUCED FROM 60.74+/-31.8 TO 42.39+/-24 KU/L. SENIOR GROUP - STATE ANXIETY SCORE DECREASED FROM 41.13 +/-8.43 TO 30.8+/-6.49, TRAIT ANXIETY SCORE REDUCED FROM 45.66+/-7.5 TO 40.73+/-8.3. YOUNGER GROUP - STATE ANXIETY SCORE REDUCED FROM 38.7+/-4.8 TO 30.8+/-4.1,TRAIT ANXIETY SCORE REDUCED FROM 46.2+/-7.9 TO 42.9+/-9.1. CHANGES WERE STATISTICALLY SIGNIFICANT WITH P<0.05. CONCLUSION: DECREASE IN SALIVARY AMYLASE ACTIVITY MAY BE DUE TO REDUCTION IN SYMPATHETIC RESPONSE. REDUCTION IN STATE AND TRAIT ANXIETY SCORE SIGNIFIES THAT YOGA HAS BOTH IMMEDIATE AS WELL AS LONG-TERM EFFECT ON ANXIETY REDUCTION. THUS YOGA HELPS TO IMPROVE THE MENTAL HEALTH IN BOTH THE GROUPS. 2011 19 930 35 EFFECTIVENESS OF YOGA PROGRAM IN THE MANAGEMENT OF DIABETES USING COMMUNITY HEALTH WORKERS IN THE URBAN SLUMS OF BANGALORE CITY: A NON-RANDOMIZED CONTROLLED TRIAL. TRIAL DESIGN: NONRANDOMIZED CONTROLLED TRIAL. METHODS: NONRANDOMIZED CONTROLLED TRIAL. THIS WAS AN INTERVENTIONAL STUDY THAT WAS CONDUCTED IN 4 SLUMS OF BENGALURU. OF THE 256 DIABETES PARTICIPANTS, ONLY 109 PEOPLE AGREED TO PARTICIPATE IN THE PROGRAM. OF 109 PEOPLE, 52 PEOPLE AGREED TO PARTICIPATE IN THE INTERVENTION (AGREED TO LEARN AND PRACTICE YOGA) WHILE THE REMAINING 57 PEOPLE WERE ASSIGNED TO NONINTERVENTION GROUP. RANDOMIZATION AND BLINDING COULD NOT BE DONE. OBJECTIVE AND OUTCOME: THE STUDY WAS CONDUCTED WITH OBJECTIVE OF ASSESSING THE EFFECTIVENESS OF YOGA, PRANAYAMA, AND SUDARSHAN KRIYA IN THE COMMUNITY-BASED MANAGEMENT OF DIABETES MELLITUS. THE PRIMARY OUTCOME VARIABLE WAS HB1AC AND SECONDARY OUTCOME VARIABLES WERE SYSTOLIC BLOOD PRESSURE (SBP), DIASTOLIC BLOOD PRESSURE (DBP), ADHERENCE TO MEDICATION, AND CHANGES IN LIFESTYLE. RESULTS: THE STUDY WAS CONDUCTED FOR 40 DAYS. COMMUNITY HEALTH WORKERS MADE A TOTAL OF 6 VISITS DURING THE STUDY. ALL THE 109 PARTICIPANTS WERE AVAILABLE FOR WEEKLY FOLLOW-UP. THERE WERE NO DROP OUTS AMONG THE STUDY POPULATION. STATISTICALLY SIGNIFICANT CHANGE WAS SEEN IN THE CONSUMPTION OF VEGETABLE (CHI(2) = 15.326, P < 0.005), FRUITS (CHI(2) = 16.207, P < 0.005), SALTY FOOD (CHI(2) = 14.823, P < 0.005), BAKERY FOOD (CHI(2) = 10.429, P < 0.005) AND FRIED FOOD (CHI(2) = 15.470, P < 0.005), ADHERENCE TO METFORMIN (CHI(2) = 41.780, P < 0.005) AND OTHER MEDICATION(CHI(2) = 21.871, P < 0.005) AND PROPORTION OF PATIENTS WITH DBP UNDER CONTROL (CHI(2) = 9.396, P < 0.005) AND PROPORTION OF PEOPLE WITH GLUCOSE RANDOM BLOOD SUGAR UNDER CONTROL (CHI(2) = 29.693, P < 0.005) BETWEEN THE TWO GROUPS FOLLOWING THE INTERVENTION. STATISTICALLY SIGNIFICANT CHANGE WAS ALSO SEEN IN THE PROPORTION OF PEOPLE WITH SBP/DBP